ELEVATE Study 410 Initial Results: Phase IV Study of Perampanel as Monotherapy or First Adjunctive Therapy in Patients Aged 4 Years with Partial-Onset Seizures (POS) or Primary Generalized Tonic-Clonic Seizures (PGTCS)